Skip to main content
SpringerLink
Log in

Is There a Role for Antiplatelet Therapy in Infective Endocarditis? A Review of Current Scientific Evidence

  • Published:
Current Infectious Disease Reports Aims and scope Submit manuscript

Abstract

Recently, interest has emerged regarding adjuvant antiplatelet therapy in infective endocarditis (IE) and its impact on clinical outcomes. Despite ongoing research, the role of antiplatelet therapy in this setting remains unclear. Generally, investigations of IE are limited by the low incidence of the disease, practical issues related to diagnosis, and the highly variable latency period between symptom onset and definitive diagnosis. This article reviews the rationale for using antiplatelet therapy in the setting of IE and the contemporary literature that investigates its use.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. Steckelberg JM, Murphy JG, Ballard D, et al.: Emboli in infective endocarditis: the prognostic value of echocardiography. Ann Intern Med 1991, 114:635–640.

    CAS  PubMed  Google Scholar 

  2. • Tleyjeh IM, Steckelberg JM, Murad HS, et al.: Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 2005, 293:3022–3028. This article delineates the epidemiology of IE in a homogenous populations, providing validity of outcome measures.

    Article  CAS  PubMed  Google Scholar 

  3. Baddour LM, Wilson WR, Baye AS, et al.: Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005, 111:e394–e434.

    Article  PubMed  Google Scholar 

  4. Delahaye JP, Poncet P, Malquarti V, et al.: Cerebrovascular accidents in infective endocarditis: role of anticoagulation. Eur Heart J 1990, 11:1074–1078.

    CAS  PubMed  Google Scholar 

  5. Heiro M, Nikoskelainen J, Engblom E, et al.: Neurologic manifestations of infective endocarditis: a 17-year experience in a teaching hospital in Finland. Arch Intern Med 2000, 160:2781–2787.

    Article  CAS  PubMed  Google Scholar 

  6. Sanfilippo AJ, Picard MH, Newell JB, et al.: Echocardiographic assessment of patients with infectious endocarditis: prediction of risk for complications. J Am Coll Cardiol 1991, 18:1191–1199.

    Article  CAS  PubMed  Google Scholar 

  7. • Anavekar NS, Tleyjeh IM, Anavekar NS, et al.: Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis. Clin Infect Dis 2007, 44:1180–1186. This article is a retrospective study that demonstrates a benefit of prior antiplatelet therapy on outcomes in patients with infective endocarditis.

    Article  PubMed  Google Scholar 

  8. Chan KL, Dumesnil JG, Cujec B, et al.: A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. J Am Coll Cardiol 2003, 42:775–780.

    Article  CAS  PubMed  Google Scholar 

  9. • Chan KL, Tam J, Dumesnil JG, et al.: Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis 2008, 46:37–41. This article describes the only major randomized controlled trial in infective endocarditis that was designed to assess utility of aspirin therapy.

    Article  PubMed  Google Scholar 

  10. • Sedlacek M, Gemery JM, Cheung AL, et al.: Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Am J Kidney Dis 2007, 49:401–408. This article provides clinical evidence for antimicrobial activity of aspirin in the setting of S. aureus bacteremia.

    Article  CAS  PubMed  Google Scholar 

  11. Kupferwasser LI, Yeaman MR, Nast CC, et al.: Salicylic acid attenuates virulence in endovascular infections by targeting global regulatory pathways in Staphylococcus aureus. J Clin Invest 2003, 112:222–233.

    CAS  PubMed  Google Scholar 

  12. Kupferwasser LI, Yeaman MR, Shapiro SM, et al.: Acetylsalicylic acid reduces vegetation bacterial density, hematogenous bacterial dissemination, and frequency of embolic events in experimental Staphylococcus aureus endocarditis through antiplatelet and antibacterial effects. Circulation 1999, 99:2791–2797.

    CAS  PubMed  Google Scholar 

  13. Nicolau DP, Freeman CD, Nightingale CH, et al.: Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun 1993, 61:1593–1595.

    CAS  PubMed  Google Scholar 

  14. Nicolau DP, Marangos MN, Nightingale CH, Quintiliani R: Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 1995, 39:1748–1751.

    CAS  PubMed  Google Scholar 

  15. Nicolau DP, Tessier PR, Nightingale CH: Beneficial effect of combination antiplatelet therapy on the development of experimental Staphylococcus aureus endocarditis. Int J Antimicrob Agents 1999, 11:159–161.

    Article  CAS  PubMed  Google Scholar 

  16. Nicolau DP, Tessier PR, Nightingale CH, Quintiliani R: Influence of adjunctive ticlopidine on the treatment of experimental Staphylococcus aureus endocarditis. Int J Antimicrob Agents 1998, 9:227–229.

    Article  CAS  PubMed  Google Scholar 

  17. Durack DT, Beeson PB: Experimental bacterial endocarditis. I. Colonization of a sterile vegetation. Br J Exp Pathol 1972, 53:44–49.

    CAS  PubMed  Google Scholar 

  18. Domenico P, Schwartz S, Cunha BA: Reduction of capsular polysaccharide production in Klebsiella pneumoniae by sodium salicylate. Infect Immun 1989, 57:3778–3782.

    CAS  PubMed  Google Scholar 

  19. Farber BF, Wolff AG: The use of nonsteroidal antiinflammatory drugs to prevent adherence of Staphylococcus epidermidis to medical polymers. J Infect Dis 1992, 166:861–865.

    CAS  PubMed  Google Scholar 

  20. Kurth T, Glynn RJ, Walker AM, et al.: Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation 2003, 108:1191–1195.

    Article  CAS  PubMed  Google Scholar 

  21. Polonio RE, Mermel LA, Paquette GE, Sperry JF: Eradication of biofilm-forming Staphylococcus epidermidis (RP62A) by a combination of sodium salicylate and vancomycin. Antimicrob Agents Chemother 2001, 45:3262–3266.

    Article  CAS  PubMed  Google Scholar 

  22. Taha TH, Durrant SS, Mazeika PK, et al.: Aspirin to prevent growth of vegetations and cerebral emboli in infective endocarditis. J Intern Med 1992, 231:543–546.

    Article  CAS  PubMed  Google Scholar 

  23. Eisen DP, Corey GR, McBryde ES, et al.: Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid. J Infect 2009, 58:332–338.

    Article  PubMed  Google Scholar 

  24. Kessler M, Hoen B, Mayeux D, et al.: Bacteremia in patients on chronic hemodialysis. A multicenter prospective survey. Nephron 1993, 64:95–100.

    Article  CAS  PubMed  Google Scholar 

Download references

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

  1. Division of Cardiovascular Diseases, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Nandan S. Anavekar & Joseph G. Murphy

Authors
  1. Nandan S. Anavekar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Joseph G. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Joseph G. Murphy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anavekar, N.S., Murphy, J.G. Is There a Role for Antiplatelet Therapy in Infective Endocarditis? A Review of Current Scientific Evidence. Curr Infect Dis Rep 12, 253–256 (2010). https://doi.org/10.1007/s11908-010-0115-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11908-010-0115-2

Keywords

Search

Navigation